Financial Analysis:
Amgen (NASDAQ: AMGN) generated the total revenue of (stock picks) $3.94 billion for the quarter ended September 30th, 2011 as compared to revenue of $3.81 billion for the same period last year. The company (stock picks) reported the net profit of $454 million or earnings of $0.50 per share for the respective quarter as compared to net income of $1.23 billion or earnings of $1.28 per share last year.
The company’s total assets accumulate up to $45.76 billion out of which fixed assets have the highest proportion. The company (stock picks) maintains a strong short term liquidity position as per its current ratio of 4.60 times.
Regards,
Don
More on this topic
(What's this?)
Will Amgen Buy Out Biogen Idec?
(Investment Underground » Page n..., 1/5/12)
Investing in Innovative Human Therapeutics Called Biotech
(Invest2Success, 2/27/12)
Dendreon Rockets 17% After Critical Reveiw For Amgen's Cancer Drug
(Benzinga, 2/6/12)
5 Dividend Stocks Showing You The Money
(Investment Underground » Page n..., 9/4/11)

![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)




